Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity

It has been well-established that age-associated low-grade chronic inflammation contributes to the development of a spectrum of chronic diseases, including diabetes mellitus, ischemic heart disease, stroke, cancer, chronic kidney disease, non-alcoholic fatty liver disease and neurodegenerative disea...

Full description

Bibliographic Details
Main Authors: Leposavić Gordana, Stojić-Vukanić Zorica
Format: Article
Language:srp
Published: Pharmaceutical Association of Serbia, Belgrade, Serbia 2022-01-01
Series:Arhiv za farmaciju
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2022/0004-19632202091L.pdf
_version_ 1818246264451497984
author Leposavić Gordana
Stojić-Vukanić Zorica
author_facet Leposavić Gordana
Stojić-Vukanić Zorica
author_sort Leposavić Gordana
collection DOAJ
description It has been well-established that age-associated low-grade chronic inflammation contributes to the development of a spectrum of chronic diseases, including diabetes mellitus, ischemic heart disease, stroke, cancer, chronic kidney disease, non-alcoholic fatty liver disease and neurodegenerative diseases, which affect the quality of life of the elderly and influence their life span. This phenomenon is suggested to arise due to the weakening of the regulatory mechanisms of the immune response, and the persistence of exogenous and endogenous (reflecting oxidative cell injury) antigenic challenges, so it is referred to as oxi-inflamm-aging. Considering that the development of age-associated chronic inflammation is "silent", i.e., without clinical signs until the aforementioned complications become apparent, it is important to identify the biomarker(s) or pattern/cluster of biomarkers for this inflammation. It is also important to define new strategies to combat the "silent" damage induced by chronic inflammation. Given that at present there are no reliable biomarkers for chronic inflammation, this review points out the problems in defining biomarker(s) or patterns/clusters of biomarkers for chronic inflammation in order to stimulate further research and points to some possible routes of investigation.
first_indexed 2024-12-12T14:46:03Z
format Article
id doaj.art-91dd423251144607b6db21de0e1e78a5
institution Directory Open Access Journal
issn 0004-1963
2217-8767
language srp
last_indexed 2024-12-12T14:46:03Z
publishDate 2022-01-01
publisher Pharmaceutical Association of Serbia, Belgrade, Serbia
record_format Article
series Arhiv za farmaciju
spelling doaj.art-91dd423251144607b6db21de0e1e78a52022-12-22T00:21:06ZsrpPharmaceutical Association of Serbia, Belgrade, SerbiaArhiv za farmaciju0004-19632217-87672022-01-017229110410.5937/arhfarm72-361350004-19632202091LBiomarkers of aging-associated chronic inflammation as a prognostic factor for human longevityLeposavić Gordana0https://orcid.org/0000-0002-1341-7716Stojić-Vukanić Zorica1https://orcid.org/0000-0001-5306-0523University of Belgrade, Faculty of Pharmacy, Department of Pathobiology, SerbiaUniversity of Belgrade, Faculty of Pharmacy, Department of Microbiology and Immunology, SerbiaIt has been well-established that age-associated low-grade chronic inflammation contributes to the development of a spectrum of chronic diseases, including diabetes mellitus, ischemic heart disease, stroke, cancer, chronic kidney disease, non-alcoholic fatty liver disease and neurodegenerative diseases, which affect the quality of life of the elderly and influence their life span. This phenomenon is suggested to arise due to the weakening of the regulatory mechanisms of the immune response, and the persistence of exogenous and endogenous (reflecting oxidative cell injury) antigenic challenges, so it is referred to as oxi-inflamm-aging. Considering that the development of age-associated chronic inflammation is "silent", i.e., without clinical signs until the aforementioned complications become apparent, it is important to identify the biomarker(s) or pattern/cluster of biomarkers for this inflammation. It is also important to define new strategies to combat the "silent" damage induced by chronic inflammation. Given that at present there are no reliable biomarkers for chronic inflammation, this review points out the problems in defining biomarker(s) or patterns/clusters of biomarkers for chronic inflammation in order to stimulate further research and points to some possible routes of investigation.https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2022/0004-19632202091L.pdflongevitylow-grade chronic inflammationnon-communicable diseasesoxi-inflamm-agingbiomarkers of chronic inflammation
spellingShingle Leposavić Gordana
Stojić-Vukanić Zorica
Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity
Arhiv za farmaciju
longevity
low-grade chronic inflammation
non-communicable diseases
oxi-inflamm-aging
biomarkers of chronic inflammation
title Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity
title_full Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity
title_fullStr Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity
title_full_unstemmed Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity
title_short Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity
title_sort biomarkers of aging associated chronic inflammation as a prognostic factor for human longevity
topic longevity
low-grade chronic inflammation
non-communicable diseases
oxi-inflamm-aging
biomarkers of chronic inflammation
url https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2022/0004-19632202091L.pdf
work_keys_str_mv AT leposavicgordana biomarkersofagingassociatedchronicinflammationasaprognosticfactorforhumanlongevity
AT stojicvukaniczorica biomarkersofagingassociatedchronicinflammationasaprognosticfactorforhumanlongevity